|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 150.37 USD | -11.22% |
|
-5.00% | +8.75% |
| 08-05 | Sandoz gains on strong biosimilar growth, touts 'golden decade' | RE |
| 08-03 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.86% | -3.32% | -3.63% | +18.30% | +8.86% | +52.73% | +160.26% | +342.81% | +1,334.36% | 995B | |
| +1.04% | -2.99% | -2.07% | +14.21% | +24.47% | +50.87% | +52.38% | +48.30% | +107.33% | 614B | |
| +0.98% | -6.49% | -5.70% | +19.45% | +7.75% | +24.00% | +66.66% | +113.86% | +270.00% | 431B | |
| +1.96% | +0.83% | +7.08% | +14.51% | +11.12% | +42.80% | +37.60% | +1.83% | +45.71% | 353B | |
| +2.52% | -8.36% | -16.74% | -9.71% | -12.72% | +7.27% | +10.32% | +44.28% | +130.57% | 245B | |
| +4.57% | +5.21% | +9.00% | +23.74% | +24.60% | +35.91% | +67.64% | +74.29% | +134.84% | 210B | |
| -4.32% | -12.94% | -9.97% | +2.94% | -9.52% | -3.79% | -44.56% | -8.42% | +78.36% | 210B | |
| -2.58% | -0.73% | +0.37% | -1.29% | +7.35% | +17.16% | +67.46% | +90.13% | +63.86% | 168B | |
| +1.57% | +2.62% | +6.13% | -2.42% | +3.65% | +4.28% | -26.30% | -42.72% | -27.17% | 145B | |
| -3.43% | +0.84% | +9.46% | +11.73% | +17.96% | +38.78% | +5.19% | -7.00% | +0.55% | 135B | |
| +1.28% | +0.31% | -8.18% | +14.25% | +6.94% | +29.29% | +42.40% | +138.84% | +373.33% | 121B | |
| +0.05% | -4.56% | -4.94% | +3.15% | +4.99% | +37.12% | +42.20% | +6.27% | -9.57% | 103B | |
| +0.15% | -6.78% | -1.73% | +0.46% | -9.94% | -9.18% | -20.68% | -12.48% | +2.72% | 103B | |
| -1.21% | -6.58% | -12.40% | -18.39% | -19.86% | -10.89% | +58.15% | +65.11% | +448.98% | 69.76B | |
| +2.01% | +3.21% | -7.76% | +29.87% | +32.99% | +77.53% | -4.65% | +6.91% | -48.66% | 54.59B | |
| +2.09% | -6.03% | -2.61% | +1.19% | +11.13% | +26.75% | +22.87% | +48.10% | +14.47% | 53.57B | |
| +0.22% | -0.65% | -1.67% | -0.63% | -10.12% | -14.06% | +30.36% | -4.05% | +229.14% | 52.24B | |
| +2.24% | -3.69% | +0.38% | +9.49% | -2.43% | +4.55% | +13.66% | - | - | 42.37B | |
| +0.84% | +0.03% | +0.23% | -3.18% | +11.25% | +121.01% | +255.74% | +247.90% | -35.95% | 40.12B | |
| Average | +0.58% | -2.83% | -2.35% | +6.72% | +5.71% | +28.01% | +44.04% | +64.11% | +172.94% | 218.15B | |
| Weighted average by Cap. | +0.70% | -3.46% | -2.43% | +11.44% | +8.81% | +34.28% | +66.12% | +118.61% | +412.95% |
- Stock Market
- Stocks
- NOVN Stock
- 0K9E Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
